
In the first three quarters, the net profits of companies on the Science and Technology Innovation Board after deductions increased by 674.17% year-on-year, and R&D investment continued to lead the A-share market.
AI-generated summary
As of now, 614 companies on the Science and Technology Innovation Board have completed the disclosure of their third quarterly reports for 2026, reflecting the overall financial and R&D performance of China's technological innovation enterprises.
China News Service, Shanghai, November 1 (Gao Zhimiao) Reporters learned from the Shanghai Stock Exchange on November 1 that as of now, 614 companies on the Science and Technology Innovation Board have completed the disclosure of their third quarterly reports for 2026 (another three red-chip companies listed in multiple places will disclose in November), achieving a total operating income of 1 514.892 billion yuan (RMB, the same below), a year-on-year increase of 41.88%; net profit was 223.52 billion yuan, a year-on-year increase of 474.56%; net profit after non-deduction was 198.059 billion yuan, a year-on-year increase of 674.17%.
According to reports, the most distinctive structural feature of the performance of the Science and Technology Innovation Board companies in the first three quarters is that the net profit growth rate after non-deduction is significantly higher than the net profit growth rate. The difference between the two is about 200 percentage points, which means that the main business of the Science and Technology Innovation Board companies contributes extremely prominently to profit growth. Looking at the profit growth structure, 322 of the 614 companies achieved net profit growth and 121 doubled their net profits. Driven by industrial prosperity, increased product volume, increased share, and increased production capacity utilization, the performance of key industrial chains such as artificial intelligence, integrated circuits, innovative drugs, and advanced materials increased significantly.
The “subject content” of the Science and Technology Innovation Board continues to increase. In the first three quarters, the total R&D investment of companies on the Science and Technology Innovation Board reached 147.111 billion yuan, a year-on-year increase of 25.83%. The median ratio of R&D investment to operating income was 12.64%, continuing to lead the A-share sectors. The R&D intensity of 188 companies exceeded 20%, accounting for 31% of the total number of companies, an increase of 6 percentage points compared with the same period last year. Among them, the R&D investment of 37 science and technology growth-level companies totaled 14.534 billion yuan, a year-on-year increase of 18%. The median R&D intensity reached 38.26%, and the "intensity" and "thickness" of innovation investment increased simultaneously.
Regarding the performance trends in the fourth quarter of this year and next year, many leading companies have recently given positive outlooks. Changxin Technology's management recently stated that driven by the demand brought about by the rapid development of AI (artificial intelligence) applications, the company still received strong demand for products from server customers in the fourth quarter, and the short supply of DRAM (dynamic random access memory) will continue. The company's revenue in the fourth quarter is expected to continue to maintain a growth trend. China Microelectronics recently stated that in the next few years, it will cover more than 60% of the high-end integrated circuit equipment market and more than 70% of the advanced packaging equipment market through independent development and epitaxial mergers and acquisitions, becoming the world's leading high-end equipment platform company.
AI outlook — possibilities, not facts
Changxin Technology’s fourth-quarter revenue continues to maintain growth trend
Likely · Within months

At the 140th Canton Fair, Chinese high-end medical equipment such as smart capsule gastroscopy and endoscopic surgery robots attracted the attention of overseas buyers from Angola, the United Kingdom and other places. Chinese medical device companies are improving product competitiveness and expanding overseas markets through technological innovation and globalization.

S&P Global Ratings lowered the outlook on Meta's credit rating from "stable" to "negative", mainly due to the surge in AI infrastructure capital expenditures and significant uncertainty in free cash flow. Although Meta's stock price fell into a technical bear market, some non-tech companies such as Santander and Novartis said that AI investments have begun to pay off.

The People's Bank of China launched the non-bank large-amount redemption swap facility in the bond market to cope with redemption pressure under extreme market fluctuations and prevent a vicious cycle. Officials emphasized that this move is not a disguised form of capital preservation for financial products, but rather a rescue plan without covering up the bottom line, aiming to maintain market stability.

South Korea's exports in October increased by 93.7% year-on-year to US$115.28 billion, the largest increase since 1974. Mainly driven by strong demand for AI-related semiconductors and servers, exports to China and the United States have grown significantly. The Ministry of Trade, Industry and Energy of South Korea predicts that the full-year export volume is expected to exceed the US$1 trillion milestone in November.

The results of the U.S. midterm elections will affect AI industry review, clean energy and defense policies, which will in turn affect the market performance of Asian AI concept stocks such as Taiwan, South Korea and Japan. Investors are worried that policy uncertainty may trigger a pullback in technology stocks.

The China Federation of Logistics and Purchasing released the 2026 Bulk Commodity Price Index Report. It is expected that the average index for the whole year will be 132.1 points, a year-on-year increase of 17.6%. Despite the global economic downturn and geopolitical challenges, China's commodity market still shows strong resilience, with non-ferrous metals, chemicals and energy prices rising significantly.